When peripheral artery disease (PAD) is known to accompany coronary artery disease (CAD) in people with diabetes, their already elevated risk of peripheral ischemic events rises even further. But so does the degree of protection conferred by addition of the antiplatelet drug ticagrelor (Brilinta, AstraZeneca) to daily low-dose aspirin, suggests a subanalysis of the THEMIS trial.
As previously reported, THEMIS saw a moderate but significant reduction in risk for cardiovascular death, myocardial infarction (MI), or stroke over an average of 40 months in more than 19,000 patients with diabetes and stable CAD randomly assigned to receive ticagrelor on top of low-dose aspirin or aspirin alone.
But there was also a jump in major bleeding complications on the chronic dual-antiplatelet therapy (DAPT), despite the trial's exclusion of patients at increased bleeding risk or who need anticoagulation.
Now a THEMIS subanalysis illustrates the steep climb in risk faced by patients with diabetes and CAD who are also recognized to have PAD.
Among patients on aspirin monotherapy in the control group, those with known PAD showed almost a 50% higher risk of cardiac events and a 73% increased risk of death compared to those without PAD, not to mention a 10-fold higher risk of limb ischemic events (LIE), defined as acute limb ischemia, peripheral revascularization, or major amputation of vascular etiology.
Hazard Ratio (HR)a for Outcomes Among 9601 Patients on Aspirin Plus Placebo in THEMIS, PAD vs No PAD
End Points
HR (95% CI)
Major adverse cardiac events
1.48 (1.20 - 1.81)
Death from any cause
1.73 (1.38 - 2.17)
Limb ischemic events
10.67 (7.90 - 14.40)
Peripheral revascularization
10.54 (7.72 - 14.38)
Major amputation of vascular etiology
9.96 (3.74 - 26.55)
Acute limb ischemia
5.61 (2.08 - 15.18)
aAll HRs, P < .001
But in ticagrelor-treated patients compared with the control group, the risk of LIE went down a significant 23% independently of whether patients had known PAD. The benefit was by more than 50% for major adverse limb events (MALE), a composite of prospectively adjudicated acute limb ischemia or amputation of vascular etiology; by more than 20% for peripheral revascularization; and by 76% for acute limb ischemia.
"So we see consistency amongst all of these components of adverse limb outcomes in the overall population," said Marc P. Bonaca, MD, MPH, University of Colorado School of Medicine, Aurora, when presenting the THEMIS substudy September 1 during the virtual European Society of Cardiology (ESC) Congress 2020.
"Those benefits were consistent regardless of PAD status at baseline," he said. "And because the risks were so high in those with PAD, their absolute benefit was greater over the course of the trial."
Limb Ischemic Outcomes at 3 Years, Ticagrelor vs Placebo, in 19,220 Patients
End Point
Placebo (%)
Ticagrelor (%)
HR (95% CI)
LIE
1.59
1.30
0.77 (0.61 - 0.96) P = .022
Peripheral revascularization
1.51
1.23
0.79 (0.62 - 0.99)
Acute limb ischemia
0.16
0.04
0.24 (0.08 - 0.70)
Major amputation of vascular etiology
0.12
0.10
0.63 (0.28 - 1.38)
MALE
0.30
0.10
0.45 (0.23 - 0.86)
The findings suggest that THEMIS-like patients with PAD may represent "a population that gets particular benefit from ticagrelor, as part of chronic DAPT, for both cardiovascular and peripheral vascular outcomes," Bonaca said.
THEMIS overall had shown a primary efficacy end point benefit that was somewhat canceled by an increased risk of bleeding; there was no significant difference in the exploratory end point of "net clinical benefit." But another substudy that had been reported at about the same time showed a significant net clinical benefit from ticagrelor among the patient subgroup with a history of percutaneous coronary intervention (PCI), Bonaca observed for theheart.org | Medscape Cardiology.
The current analysis highlights yet another "decision point" for THEMIS-like patients, in this case those with PAD, he said in an interview. It suggests a potential opportunity to go beyond ticagrelor's labeling, which indicates the drug for reducing MI and stroke. "There's actually a real benefit for limb outcomes."
Importantly, he said, in an analysis that stratified patients by their PAD status, those with known PAD with their dramatically higher baseline risk showed about a 2 percentage-point absolute advantage for LIE.
"As you weigh the potential benefits against the potential risks of bleeding for the patient with coronary disease, PAD, and diabetes, they're going to get a bigger benefit if you look at the global metrics of benefit for the limbs, heart, and brain than a patient without PAD," he said.
Rates of Limb Ischemic Events, Ticagrelor vs Placebo, by PAD Statusa
Population Cohorts
Placebo (%)
Ticagrelor (%)
HR (95% CI)
LIE overall, n = 19,220
1.59
1.30
0.77 (0.61 - 0.96)
LIE with PAD, n = 1687
9.50
7.60
0.80 (0.58 - 1.11)
LIE with no PAD, n = 17,533
0.80
0.70
0.76 (0.55 - 1.05)
aP = .81 for interaction between presence of known PAD and treatment-group effect on ischemic limb events
Patients with diabetes and polyvascular disease that includes PAD certainly need antithrombotic therapy beyond a single antiplatelet agent, "because these patients have such high risk," agreed Aaron W. Aday, MD, MSc, Vanderbilt University Medical Center, Nashville, Tennessee, in an interview with theheart.org | Medscape Cardiology.
But he hasn't generally been a proponent of DAPT in that setting. "For me, COMPASS was very practice changing," said Aday, who wasn't part of THEMIS.
In the COMPASS trial, reported and covered in these pages 3 years ago, low-dose rivaroxaban (Xarelto, Bayer/Janssen Pharmaceuticals) when added to low-dose aspirin led to a 28% drop in risk for cardiovascular death, stroke, or MI, and a 46% reduced risk for major adverse limb events (P = .005 for both benefits). But there was also a 61% increase in major bleeding on rivaroxaban plus aspirin (P = .009).
Aday said he uses low-dose rivaroxaban with aspirin routinely in his patients with PAD, especially "those who are very symptomatic or who've had prior interventions, and certainly in those who have symptomatic disease in other vascular beds."
The current THEMIS findings are "intriguing," he said, but added he wants to see the analysis fleshed out in publication before making further judgment.
Still, "there are some patients for whom, for whatever reason, maybe rivaroxaban is not the right drug," he said. They have renal insufficiency or some other contraindication, or maybe cost is an issue.
"I'm not comfortable leaving them on just antiplatelet monotherapy" So perhaps ticagrelor plus aspirin would be "a reasonable option" to consider for such patients. But compared with the COMPASS regimen, "is this an equivalent option? Is it superior or inferior? I think we'll need to see more data," Aday said.
Bonaca cautions that the THEMIS analysis says nothing about ticagrelor's risk vs benefit in such patients with prior peripheral endovascular or surgical intervention and should not be interpreted as suggesting those patients will benefit.
"Not only do we not know the efficacy in that setting, we don't know the safety, what the bleeding would be like," he said. "And I think that really requires a dedicated study."
THEMIS was funded by AstraZeneca. Bonaca reported institutional grant support from Amgen, AstraZeneca, Bayer Janssen, and Merck. Aday reported payment for consulting from OptumCare.
European Society of Cardiology Congress 2020: Late Breaking Science in Cardiovascular Pharmacotherapy. Presented September 1, 2020.
Follow Steve Stiles on Twitter: @SteveStiles2. For more from theheart.org | Medscape Cardiology, follow us on Twitter and Facebook.
Original post:
Extra Ticagrelor Benefit When PAD Adds to CAD, Diabetes: THEMIS - Medscape
- ST-Segment Elevation Myocardial Infarction - verywell.com [Last Updated On: May 12th, 2018] [Originally Added On: May 12th, 2018]
- Myocardial infarction (Heart Attack) - Health Facts [Last Updated On: June 21st, 2018] [Originally Added On: June 21st, 2018]
- Heart Attack and Acute Coronary Syndrome - Lab Tests Online [Last Updated On: June 21st, 2018] [Originally Added On: June 21st, 2018]
- Myocardial Infarction - ECGpedia [Last Updated On: September 21st, 2018] [Originally Added On: September 21st, 2018]
- Myocardial Infarction Clinical Presentation: History ... [Last Updated On: September 25th, 2018] [Originally Added On: September 25th, 2018]
- Myocardial infarction diagnosis - Wikipedia [Last Updated On: September 25th, 2018] [Originally Added On: September 25th, 2018]
- Myocardial Infarction Treatment & Management: Approach ... [Last Updated On: October 9th, 2018] [Originally Added On: October 9th, 2018]
- Myocardial infarction - Simple English Wikipedia, the free ... [Last Updated On: October 18th, 2018] [Originally Added On: October 18th, 2018]
- ST-Segment Elevation Myocardial Infarction [Last Updated On: October 18th, 2018] [Originally Added On: October 18th, 2018]
- ECG localization of myocardial infarction / ischemia and ... [Last Updated On: October 18th, 2018] [Originally Added On: October 18th, 2018]
- Heart Attack (Myocardial Infarction) Symptoms | Cleveland Clinic [Last Updated On: November 15th, 2018] [Originally Added On: November 15th, 2018]
- Myocardial Infarction (Heart Attack) Ischemia Pathophysiology, ECG, Nursing, Signs, Symptoms Part 1 [Last Updated On: November 15th, 2018] [Originally Added On: November 15th, 2018]
- Myocardial Infarction (MI) NCLEX Questions [Last Updated On: November 30th, 2018] [Originally Added On: November 30th, 2018]
- Myocardial Infarction NCLEX Review (Part 1) [Last Updated On: December 3rd, 2018] [Originally Added On: December 3rd, 2018]
- Acute Myocardial Infarction, Myocardial infection. Patient [Last Updated On: December 4th, 2018] [Originally Added On: December 4th, 2018]
- Heart Attack | Myocardial Infarction | MedlinePlus [Last Updated On: December 16th, 2018] [Originally Added On: December 16th, 2018]
- Heart Attack (Myocardial Infarction) - medicinenet.com [Last Updated On: December 17th, 2018] [Originally Added On: December 17th, 2018]
- Myocardial infarction (acute): Early rule out using high ... [Last Updated On: December 20th, 2018] [Originally Added On: December 20th, 2018]
- Conditions We Treat: Myocardial Infarction | Johns Hopkins ... [Last Updated On: December 23rd, 2018] [Originally Added On: December 23rd, 2018]
- Myocardial Infarction - Heart Home Page [Last Updated On: December 25th, 2018] [Originally Added On: December 25th, 2018]
- Myocardial infarction: signs symptoms and treatment ... [Last Updated On: December 25th, 2018] [Originally Added On: December 25th, 2018]
- ECGs in Acute Myocardial Infarction - ACLS Medical Training [Last Updated On: December 25th, 2018] [Originally Added On: December 25th, 2018]
- Myocardial Infarction - Eccles Health Sciences Library [Last Updated On: December 27th, 2018] [Originally Added On: December 27th, 2018]
- Myocardial Infarction: Practice Essentials, Background ... [Last Updated On: December 27th, 2018] [Originally Added On: December 27th, 2018]
- Myocardial infarction - Wikipedia [Last Updated On: December 27th, 2018] [Originally Added On: December 27th, 2018]
- Nursing Care Plan for Myocardial Infarction | NRSNG [Last Updated On: December 29th, 2018] [Originally Added On: December 29th, 2018]
- Cardiovascular disease - Myocardial infarction | Britannica.com [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Heart Attack (Myocardial Infarction) - Cedars-Sinai [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Top 5 MI ECG Patterns You Must Know | LearntheHeart.com [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Anterior Myocardial Infarction LITFL ECG Library Diagnosis [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Electrocardiography in myocardial infarction - Wikipedia [Last Updated On: January 11th, 2019] [Originally Added On: January 11th, 2019]
- Myocardial Infarction Therapeutics Market, Share, Growth ... [Last Updated On: March 13th, 2019] [Originally Added On: March 13th, 2019]
- Heart Attack (Myocardial Infarction) - Drugs.com [Last Updated On: April 20th, 2019] [Originally Added On: April 20th, 2019]
- STEMI (ST Elevation Myocardial Infarction): diagnosis ... [Last Updated On: April 20th, 2019] [Originally Added On: April 20th, 2019]
- Heart attack - Symptoms and causes - Mayo Clinic [Last Updated On: April 20th, 2019] [Originally Added On: April 20th, 2019]
- Cardiovascular models including myocardial infarction ... [Last Updated On: April 27th, 2019] [Originally Added On: April 27th, 2019]
- Myocardial infarction - Osmosis Video Library [Last Updated On: May 1st, 2019] [Originally Added On: May 1st, 2019]
- Myocardial Infarction [Last Updated On: September 17th, 2019] [Originally Added On: September 17th, 2019]
- Creatinine Rises After RAS Inhibitor Initiation Tied to Worse Outcomes - Renal and Urology News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Ventricular Tachycardia Treatment Market Growth in Technological Innovation, Competitive Landscape Mapping the Trends and Outlook - NewsVarsity [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- FDA Action Alert: Merck and Amarin - BioSpace [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Resverlogix Provides Update on BETonMACE Phase 3 Trial Toronto Stock Exchange:RVX - GlobeNewswire [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Marijuana Use Linked to Improved Acute-HF Hospital Survival - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Population Health vs. Personalized Medicine: Lost in Translation? - American Council on Science and Health [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Bariatric Surgery Tied to Less MACE in Obesity, Diabetes - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- A Novel Algorithm for Improving the Diagnostic Accuracy of Prehospital ST-Elevation Myocardial Infarction - DocWire News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Shock and Awe: ARNI for Acute HF May Be Safely Started in ICU - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Global Myocardial Infarction Treatment Market Will Reach USD 1726.3 million by end of 2022 - Market News Store [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Frequency and Factors Related to Not Receiving Acute Reperfusion Therapy in Patients with ST Elevation Myocardial Infarction; A Single Specialty... [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Research Offers 10-Year Forecast on Myocardial Infarction Treatment Market - Rapid News Network [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- University of Colorado study suggests Cannabis aids in surviving heart... - Communities Digital News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- SRH part of regional system award recognizing care for heart attacks - Index-Journal [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- TherOx Announces Key SuperSaturated Oxygen Therapy Presentations at TCT 2019 - Yahoo Finance [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Incidence, Characteristics and Outcomes in Very Young Patients with ST Segment Elevation Myocardial Infarction - DocWire News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Health Recovery After Acute MI Similar in Young Adults With and Without Diabetes - The Cardiology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Rapid Diagnosis Protocol for Chest Pain Does Not Improve Outcomes - Diagnostic and Interventional Cardiology [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Diagnosis of Myocardial Infarction At Autopsy: AECVP Reappraisal in the Light of the Current Clinical Classification - DocWire News [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Global Myocardial Infarction Drug Market 2019 BioCardia, Inc., Biscayne Pharmaceuticals, Inc., Capricor Therapeutics, Inc., Cell - Market News Times [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Abiomed to Highlight Importance of Optimal PCI Treatment to Improve Outcomes for High-Risk Patients at TCT 2019 - Yahoo Finance [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- ENTRUST-AF PCI Supports Safety of Dual Therapy With Edoxaban - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Preoperative opioid use leads to perioperative consequences in foot and ankle surgery - Healio [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- CV, General Safety of Long-Term PPI Use Examined - The Cardiology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Effect of Delayed vs Immediate Interventions in Transient STEMI - The Cardiology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Cardiorenal Disease Is the Most Common CVD Manifestation in Patients With T2D - Endocrinology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- DAPA-HF Published: 'Stunning Consistent Benefit With Dapagliflozin' - Medscape [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Geomagnetic Disturbances and Cardiovascular Mortality Risk - On Health - BMC Blogs Network [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- Reconsidering the Safety of Intravenous Thrombolysis for Ischemic Stroke After Recent Myocardial Infarction - Neurology Advisor [Last Updated On: September 19th, 2019] [Originally Added On: September 19th, 2019]
- The Lowdown on Lipoprotein(a) - Medscape [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Protamine use found to significantly reduce reoperations for patients who undergo carotid endarterectomy - Vascular News [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Left Main Treated With PCI or CABG Have Similar Outcomes at Five Years - Diagnostic and Interventional Cardiology [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Sen. Sanders released from the hospital after heart attack - WXYZ [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- E-Selectin Gene Haplotypes are Associated with the Risk of Myocardial Infarction - DocWire News [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- BioVentrix Enrolls and Treats First Patient in REVIVE-HF European RCT for Ischemic Heart Failure Patients - P&T Community [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Quantitative Flow Ratio guided Residual Functional SYNTAX Score for Risk Assessment in Patients with ST-Segment Elevation Myocardial Infarction... [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Coronary Calcium Scan: The Role of Calcium Scoring in Preventing a First Myocardial Infarction - Consultant360 [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Sanders plans to 'change the nature' of campaign after heart attack - New York Post [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Early MI Linked to High Recurrent Events, Mortality - Medscape [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Sudden Cardiac Arrest and Ventricular Arrhythmias following first type I Myocardial Infarction in the Contemporary Era - DocWire News [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- E-Cigarette Use and Myocardial Infarction - Physician's Weekly [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]
- Sen. Bernie Sanders had heart attack; chest pains diagnosed as myocardial infarction - KIRO Seattle [Last Updated On: October 9th, 2019] [Originally Added On: October 9th, 2019]